[
  {
    "id": "target",
    "nice_name": "Target",
    "key": [
      "target/id"
    ],
    "description": "Core annotation for drug targets (gene/proteins). Targets are defined based on EMBL-EBI Ensembl database and uses the Ensembl gene ID as the  primary identifier. An Ensembl gene ID is considered potential drug target if included in the canonical assembly or if present alternative assemblies but encoding for a reviewed protein product according to the UniProt database.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "disease",
    "nice_name": "Disease/Phenotype",
    "key": [
      "disease/id"
    ],
    "description": "Core annotation for diseases or phenotypes. A disease or phenotype in the Platform is understood as any disease, phenotype, biological process or measurement that might have any type of causality relationship with a human target. The EMBL-EBI Experimental Factor Ontology (EFO) (slim version) is used as scaffold for the disease or phenotype entity.",
    "tags": [
      "Disease"
    ]
  },
  {
    "id": "drug_molecule",
    "nice_name": "Drug/Clinical candidates",
    "key": [
      "drug_molecule/id"
    ],
    "description": "Core annotation for drug or clinical candidate molecules. A drug in the Platform is understood as any bioactive molecule with drug-like properties included in the EMBL-EBI ChEMBL database. All ChEMBL molecules fullfilling any of the next criteria are included in the database: a) molecules with a known indication, b) molecules with a known mechanism of action, c) ChEMBL molecules included in the DrugBank database, d) Molecules that are acknowledged as chemical probes.",
    "tags": [
      "Drug"
    ]
  },
  {
    "id": "interaction",
    "nice_name": "Molecular interactions",
    "key": [
      "interaction/targetA",
      "interaction/targetB",
      "interaction/intA",
      "interaction/intB",
      "interaction/sourceDatabase",
      "interaction/intABiologicalRole",
      "interaction/intBBiologicalRole"
    ],
    "description": "Integration of molecular interactions reporting experimental or functional interactions between molecules represented as Platform targets. This dataset contains pairwise interactions deposited in several databases capturing: physical interactions (e.g. IntAct), directional interactions (e.g. Signor), pathway relationships (e.g. Reactome) or functional interactions (e.g. STRINGdb).",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "interaction_evidence",
    "nice_name": "Molecular interactions evidence",
    "key": [
      "interaction_evidence/targetA",
      "interaction_evidence/targetB",
      "interaction_evidence/intA",
      "interaction_evidence/intB",
      "interaction_evidence/intABiologicalRole",
      "interaction_evidence/intBBiologicalRole",
      "interaction_evidence/interactionResources",
      "interaction_evidence/interactionIdentifier",
      "interaction_evidence/interactionDetectionMethodMiIdentifier",
      "interaction_evidence/expansionMethodMiIdentifier",
      "interaction_evidence/evidenceScore"
    ],
    "description": "Experimental evidence supporting molecular interactions ('interaction') dataset.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "expression",
    "nice_name": "Baseline expression",
    "key": [
      "expression/id"
    ],
    "description": "Baseline RNA and protein expression data across tissues. This data does not contain raw expression values, instead shows how targets are selectively expressed across different tissues. This dataset combines expression values from multiple sources including Expression Atlas and Human Protein Atlas.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "go",
    "nice_name": "Target - gene ontology",
    "key": [
      "go/id"
    ],
    "description": "This dataset contains the mapping between gene ontology identifiers and terms.",
    "tags": [
      "Ontology"
    ]
  },
  {
    "id": "disease_phenotype",
    "nice_name": "Disease/Phenotype - clinical signs and symptoms",
    "key": [
      "disease_phenotype/disease",
      "disease_phenotype/phenotype"
    ],
    "description": "Clinical signs and symptoms observed in diseases or phenotypes. Signs and symptoms are integrated from multiple sources including EFO, MONDO and HPO.",
    "tags": [
      "Disease"
    ]
  },
  {
    "id": "drug_mechanism_of_action",
    "nice_name": "Drug - mechanism of action",
    "key": [
      "drug_mechanism_of_action/chemblIds",
      "drug_mechanism_of_action/mechanismOfAction",
      "drug_mechanism_of_action/targets"
    ],
    "description": "Mechanisms of action for drug or clinical candidate molecules included in ChEMBL database. The mechanism of action includes information about the pharmacological target of the drug, the mode of action and the drug modality.",
    "tags": [
      "Drug"
    ]
  },
  {
    "id": "drug_indication",
    "nice_name": "Drug - indications",
    "key": [
      "drug_indication/id"
    ],
    "description": "Approved and investigational indications for drug or clinical candidate molecules. Indications are integrated by the ChEMBL database from a diverse range of sources including DailyMed, FDA and EMA.",
    "tags": [
      "Drug"
    ]
  },
  {
    "id": "drug_warning",
    "nice_name": "Drug - withdrawn and black box warnings",
    "key": [
      "drug_warning/id"
    ],
    "description": "Blackbox and withdrawn information for drug molecules included in ChEMBL database.",
    "tags": [
      "Drug"
    ]
  },
  {
    "id": "pharmacogenomics",
    "nice_name": "Drug/Target - pharmacogenetics",
    "key": [
      "pharmacogenomics/datasourceId",
      "pharmacogenomics/genotypeAnnotationText",
      "pharmacogenomics/haplotypeId",
      "pharmacogenomics/phenotypeText",
      "pharmacogenomics/phenotypeFromSourceId",
      "pharmacogenomics/studyId",
      "pharmacogenomics/targetFromSourceId",
      "pharmacogenomics/drugs",
      "pharmacogenomics/pgxCategory",
      "pharmacogenomics/variantId",
      "pharmacogenomics/variantFunctionalConsequenceId"
    ],
    "description": "Genetic variants influencing individual drug responses. Pharmacogenetics data is integrated from sources including ClinPGx.",
    "tags": [
      "Target",
      "Genetics"
    ]
  },
  {
    "id": "reactome",
    "nice_name": "Target - Reactome pathway information",
    "key": [
      "reactome/id"
    ],
    "description": "Pathway metadata from Reactome pathway database.",
    "tags": [
      "Ontology"
    ]
  },
  {
    "id": "target_validation",
    "nice_name": "Target - prioritisation",
    "key": [
      "target_validation/targetId"
    ],
    "description": "Target-specific properties used to prioritise targets for further prioritisation (prioritisation view). All prioritisation factors included in the dataset range from -1 (unfavourable) to 1 (favourable). The prioritisation factors are derived from several sources related to the clinical precedence, tractability, doability and safety of a target.",
    "tags": null
  },
  {
    "id": "target_essentiality",
    "nice_name": "Target - DepMap essentiality",
    "key": [
      "target_essentiality/id"
    ],
    "description": "Target essentiality assessments based on dependencies exhibited when knocking-out genes in cancer cellular models using CRISPR screenings as reported in by the Cancer DepMap Project. Gene effects below -1 can be considered dependencies.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "openfda_significant_adverse_target_reactions",
    "nice_name": "Pharmacovigilance (by target)",
    "key": [
      "openfda_significant_adverse_target_reactions/targetId",
      "openfda_significant_adverse_target_reactions/event"
    ],
    "description": "Significant adverse events (adverse drug reactions, ADR) associated with drugs sharing the same pharmacological target. This dataset is based on the FDA's Adverse Event Reporting System (FAERS) of post-marketing surveillance data and is filtered to include only reports submitted by health professionals. The significance of a given target-ADR is estimated using a Likelihood Ratio Test (LRT) using all reports associated with the drugs with the same target.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "openfda_significant_adverse_drug_reactions",
    "nice_name": "Pharmacovigilance (by drug)",
    "key": [
      "openfda_significant_adverse_drug_reactions/chembl_id",
      "openfda_significant_adverse_drug_reactions/event"
    ],
    "description": "Significant adverse drug reactions (ADRs) associated with drugs. This dataset is based on the FDA's Adverse Event Reporting System (FAERS) reporting post-marketing surveillance data and it's filtered to include only reports submitted by health professionals. The significance of a given drug-ADR is estimated using a Likelihood Ratio Test (LRT) using all reports associated with the given drug.",
    "tags": [
      "Drug"
    ]
  },
  {
    "id": "biosample",
    "nice_name": "Biosample core annotation",
    "key": [
      "biosample/biosampleId"
    ],
    "description": "Integration of biosample metadata about tissues or cell types derived from multiple ontologies including EFO, UBERON, CL, GO and others.",
    "tags": [
      "Ontology"
    ]
  },
  {
    "id": "colocalisation_coloc",
    "nice_name": "Colocalisation with coloc",
    "key": [
      "colocalisation_coloc/leftStudyLocusId",
      "colocalisation_coloc/rightStudyLocusId"
    ],
    "description": "GWAS-GWAS and GWAS-molQTL credible set colocalisation results using coloc method. Dataset includes colocalising pairs as well as the method and statistics used to estimate the colocalisation.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "colocalisation_ecaviar",
    "nice_name": "Colocalisation with eCAVIAR",
    "key": [
      "colocalisation_ecaviar/leftStudyLocusId",
      "colocalisation_ecaviar/rightStudyLocusId"
    ],
    "description": "GWAS-GWAS and GWAS-molQTL credible set colocalisation results using eCAVIAR method. Dataset includes colocalising pairs as well as the method and statistics used to estimate the colocalisation.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "credible_set",
    "nice_name": "Credible set",
    "key": [
      "credible_set/studyLocusId"
    ],
    "description": "95% credible sets for GWAS and molQTL studies. Credible sets include all variants in the credible set as well as the fine-mapping method and statistics used to estimate the credible set.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "variant",
    "nice_name": "Variant",
    "key": [
      "variant/variantId"
    ],
    "description": "Core variant information for all variants in the Platform. Variants are included if any phenotypic information is available for the variant, including GWAS or molQTL credible sets, ClinVar, Uniprot or ClinPGx. The dataset includes variant metadata as well as variant effects derived from Ensembl VEP.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "l2g_prediction",
    "nice_name": "Locus-to-Gene (L2G) prediction",
    "key": [
      "l2g_prediction/studyLocusId",
      "l2g_prediction/geneId"
    ],
    "description": "Predictions from our Locus-to-Gene (L2G) gene assignment model. The dataset contains all predictions for every combination of credible set and genes in the region as well as statistics to explain the model interpretation of the predictions.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "study",
    "nice_name": "GWAS Study",
    "key": [
      "study/studyId"
    ],
    "description": "Metadata for all complex trait and molecular QTL GWAS studies in the Platform. The dataset includes study metadata, phenotype information, sample sizes, publication information and more. Molecular QTL studies are split by the affected gene, tissue or cell type and condition, potentially leading to many studies in the same publication.",
    "tags": [
      "Genetics"
    ]
  },
  {
    "id": "disease_hpo",
    "nice_name": "Human Phenotype Ontology",
    "key": [
      "disease_hpo/id"
    ],
    "description": "Human Phenotype Ontology subset of information included in the Platform.",
    "tags": [
      "Ontology"
    ]
  },
  {
    "id": "so",
    "nice_name": "Sequence Ontology",
    "key": [
      "so/id"
    ],
    "description": "Sequence ontology lookup table.",
    "tags": [
      "Ontology"
    ]
  },
  {
    "id": "target_prioritisation",
    "nice_name": "Target Prioritisation",
    "key": [
      "target_prioritisation/targetId"
    ],
    "description": "List of target-specific attributes from the Target Engine project.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "association_overall_direct",
    "nice_name": "Associations - direct (overall score)",
    "key": [
      "association_overall_direct/diseaseId",
      "association_overall_direct/targetId"
    ],
    "description": "Overall metrics for direct target-disease associations. Dataset contains the overall association score for the aggregation of all evidence supporting any given target-disease. This dataset only contains direct associations, therefore no evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "association_overall_indirect",
    "nice_name": "Associations - indirect (overall score)",
    "key": [
      "association_overall_indirect/diseaseId",
      "association_overall_indirect/targetId"
    ],
    "description": "Overall metrics for direct target-disease associations. Dataset contains the overall association score for the aggregation of all evidence supporting any given target-disease. This dataset contains indirect associations, therefore evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "association_by_datatype_direct",
    "nice_name": "Associations - direct (by data type)",
    "key": [
      "association_by_datatype_direct/diseaseId",
      "association_by_datatype_direct/targetId",
      "association_by_datatype_direct/datatypeId"
    ],
    "description": "Data type-specific metrics for direct target-disease associations. Dataset contains association scores calculated for each data type indepedently for the aggregation of all evidence supporting any given target-disease. This dataset only contains direct associations, therefore no evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "association_by_datatype_indirect",
    "nice_name": "Associations - indirect (by data type)",
    "key": [
      "association_by_datatype_indirect/diseaseId",
      "association_by_datatype_indirect/targetId",
      "association_by_datatype_indirect/datatypeId"
    ],
    "description": "Data type-specific metrics for direct target-disease associations. Dataset contains association scores calculated for each data type indepedently for the aggregation of all evidence supporting any given target-disease. This dataset contains indirect associations, therefore evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "association_by_datasource_indirect",
    "nice_name": "Associations - indirect (by data source)",
    "key": [
      "association_by_datasource_indirect/diseaseId",
      "association_by_datasource_indirect/targetId",
      "association_by_datasource_indirect/datasourceId"
    ],
    "description": "Data source-specific metrics for direct target-disease associations. Dataset contains association scores calculated for each data source indepedently for the aggregation of all evidence supporting any given target-disease. This dataset contains indirect associations, therefore evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "association_by_datasource_direct",
    "nice_name": "Associations - direct (by data source)",
    "key": [
      "association_by_datasource_direct/diseaseId",
      "association_by_datasource_direct/targetId",
      "association_by_datasource_direct/datasourceId"
    ],
    "description": "Data source-specific metrics for direct target-disease associations. Dataset contains association scores calculated for each data source indepedently for the aggregation of all evidence supporting any given target-disease. This dataset only contains direct associations, therefore no evidence is propagated across the disease or phenotype space using the Experimental Factor Ontology.",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "known_drug",
    "nice_name": "Known drug",
    "key": [
      "known_drug/drugId",
      "known_drug/targetId",
      "known_drug/diseaseId",
      "known_drug/phase",
      "known_drug/status"
    ],
    "description": "Information on the target gene product and indication for any approved or clinical candidate drug. It is derived from the ChEMBL target/disease evidence.",
    "tags": [
      "Target",
      "Drug"
    ]
  },
  {
    "id": "mouse_phenotype",
    "nice_name": "Mouse phenotype",
    "key": [
      "mouse_phenotype/modelPhenotypeId",
      "mouse_phenotype/targetFromSourceId",
      "mouse_phenotype/targetInModelMgiId"
    ],
    "description": "Phenotypes of mouse models mapped to human targets.",
    "tags": [
      "Target"
    ]
  },
  {
    "id": "literature",
    "nice_name": "Literature",
    "key": [
      "literature/pmid",
      "literature/pmcid",
      "literature/keywordId"
    ],
    "description": "Unique list of entities identified for each literature entry.",
    "tags": [
      "Literature"
    ]
  },
  {
    "id": "literature_vector",
    "nice_name": "Literature vector",
    "key": [
      "literature_vector/word"
    ],
    "description": "Word to Vector representation of entity matches in literature.",
    "tags": [
      "Literature"
    ]
  },
  {
    "id": "otar",
    "nice_name": "Open Targets Projects",
    "key": [
      "otar/efo_id"
    ],
    "description": "Open Targets projects grouped by studied disease or phenotype.",
    "tags": null
  },
  {
    "id": "interval",
    "nice_name": "Genomic intervals",
    "key": [
      "interval/intervalId"
    ],
    "description": "Genomic regions (intervals) associated with genes based on epigenetics evidence.",
    "tags": [
      "Target",
      "Genetics"
    ]
  },
  {
    "id": "evidence_cancer_biomarkers",
    "nice_name": "Cancer biomarker evidence",
    "key": [
      "evidence_cancer_biomarkers/id"
    ],
    "description": "Disease-target evidence based on cancer biomarkers from the Cancer Genome Interpreter",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_cancer_gene_census",
    "nice_name": "Cancer Gene Census evidence",
    "key": [
      "evidence_cancer_gene_census/id"
    ],
    "description": "Disease-target evidence based on Cancer Gene Census provided by COSMIC",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_chembl",
    "nice_name": "ChEMBL evidence",
    "key": [
      "evidence_chembl/id"
    ],
    "description": "Disease-target evidence based on drug indications, clinical trials and mechanism of action provided by ChEMBL",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_clingen",
    "nice_name": "ClinGen evidence",
    "key": [
      "evidence_clingen/id"
    ],
    "description": "Disease-target evidence from Gene\u2013Disease Validity Curation of ClinGen",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_crispr",
    "nice_name": "ProjectScore evidence",
    "key": [
      "evidence_crispr/id"
    ],
    "description": "Diease-target evidence from unified analysis of whole-genome CRISPR/Cas9 screens from ProjectScore project",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_crispr_screen",
    "nice_name": "CRISP screen evidence",
    "key": [
      "evidence_crispr_screen/id"
    ],
    "description": "Disease-target evidence derived from systematic gene perturation assays of CRISPR knock-out screens",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_encore",
    "nice_name": "Open Targets - Encore evidence",
    "key": [
      "evidence_encore/id"
    ],
    "description": "Disease-target evidence based on somatic variation from ClinVar, provided by the European Variation Archive",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_europepmc",
    "nice_name": "EuropePMC evidence",
    "key": [
      "evidence_europepmc/id"
    ],
    "description": "Disease-target evidence derived from literature mining provided by Europe PMC",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_eva",
    "nice_name": "ClinVar germ-line evidence",
    "key": [
      "evidence_eva/id"
    ],
    "description": "Disease-target evidence based on germline variation from ClinVar, provided by the European Variation Archive",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_eva_somatic",
    "nice_name": "ClinVar somatic evidence",
    "key": [
      "evidence_eva_somatic/id"
    ],
    "description": "Disease-target evidence based on somatic variation from ClinVar, provided by the European Variation Archive",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_expression_atlas",
    "nice_name": "Differential expression evidence",
    "key": [
      "evidence_expression_atlas/id"
    ],
    "description": "Disease-target evidence based on differential expression data provided by Expression Atlas",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_gene_burden",
    "nice_name": "Gene burden evidence",
    "key": [
      "evidence_gene_burden/id"
    ],
    "description": "Disease-target evidence based on testing aggregated effect of variants, curated from the literature by the Open Targets team",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_gene2phenotype",
    "nice_name": "Gene2Phenotype evidence",
    "key": [
      "evidence_gene2phenotype/id"
    ],
    "description": "Disease-target evidence curated by the Gene2Phenotype consortium",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_genomics_england",
    "nice_name": "Genomics England - PanelApp evidence",
    "key": [
      "evidence_genomics_england/id"
    ],
    "description": "Curated disease-target evidence provided by Genomics England PanelApp",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_gwas_credible_sets",
    "nice_name": "GWAS credible-set evidence",
    "key": [
      "evidence_gwas_credible_sets/id"
    ],
    "description": "Disease-target evidence based on Locus-to-Gene prediction on GWAS credible sets",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_impc",
    "nice_name": "IMPC evidence",
    "key": [
      "evidence_impc/id"
    ],
    "description": "Disease-target evidence based on mouse knock-out models, where mouse phenotypes are mapped to human diseases by PhenoDigm algorithm. Data provided by IMPC",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_intogen",
    "nice_name": "IntOGen evidence",
    "key": [
      "evidence_intogen/id"
    ],
    "description": "Cancer-driver gene evidence based on the analysis of large-scale mutational data from IntOGen",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_orphanet",
    "nice_name": "Orphanet evidence",
    "key": [
      "evidence_orphanet/id"
    ],
    "description": "Curated collection of rare disase-target evidence from Orphanet",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_ot_crispr",
    "nice_name": "Open Targets - CRISPR screen evidence",
    "key": [
      "evidence_ot_crispr/id"
    ],
    "description": "Pre-publication CRISPR/Cas9 perturation screens provided by Open Targets experimental projects",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_ot_crispr_validation",
    "nice_name": "Open Targets - Validation Lab evidence",
    "key": [
      "evidence_ot_crispr_validation/id"
    ],
    "description": "Disease-target evidence derived from CRISPR/Cas9 perturation screens provided by Open Targets Validation lab",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_reactome",
    "nice_name": "Reactome evidence",
    "key": [
      "evidence_reactome/id"
    ],
    "description": "Manually curated disease-target evidence based on reaction pathways sourced from Reactome",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_uniprot_literature",
    "nice_name": "Uniprot literature evidence",
    "key": [
      "evidence_uniprot_literature/id"
    ],
    "description": "Protein-disease evidence based on literature curated by the Uniprot team",
    "tags": [
      "Target-Disease"
    ]
  },
  {
    "id": "evidence_uniprot_variants",
    "nice_name": "Uniprot variants evidence",
    "key": [
      "evidence_uniprot_variants/id"
    ],
    "description": "Disease-target evidence based on disease causing protein sequence alteration curated by the Uniprot team",
    "tags": [
      "Target-Disease"
    ]
  }
]
